From the Addiction Service (PP), Caremeau Hospital, Place du Pr Debré, CHU, Nîmes, France; University of Montpellier 1 (PP, HR), France; Department of Addiction and Internal Medicine (HR), CHU Montpellier, France; The Scripps Research Institute (BM), La Jolla, CA; Univ. Grenoble Alpes (MD), HP2, F-38000 Grenoble, France; INSERM (MD), HP2, U1042, F-38000 Grenoble, France; CHU de Grenoble (MD), Department of Addiction Medicine, HP2, F-38000 Grenoble, France; Faculty of Medicine (PL), University of Melbourne, Australia; and Faculty of Economics (PL), Louvain University, Belgium.
Send correspondence and reprint requests to Pascal Perney, MD, PhD, Addiction Service, Caremeau Hospital, Place du Pr Debré, 30029 Nîmes, France. E-mail: [email protected].
Supported in part by an unrestricted educational grant from Merck-Serono.
The authors declare no other conflicts of interest.
Received January 11, 2014
Accepted June 09, 2014